UK markets closed

Gossamer Bio, Inc. (GOSS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.7352+0.0024 (+0.33%)
As of 02:16PM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-172,580
-179,817
-229,378
-234,004
-243,360
Depreciation & amortisation
4,231
4,385
4,429
5,167
4,268
Stock-based compensation
26,202
28,518
42,553
32,008
38,748
Change in working capital
-17,647
-14,841
-4,459
774
-3,095
Accounts payable
-157
3,990
-1,813
-4,428
6,984
Other working capital
-158,456
-159,158
-187,507
-190,511
-201,243
Other non-cash items
11,247
11,321
1,228
6,806
27,237
Net cash provided by operating activities
-158,471
-159,158
-187,032
-188,890
-176,360
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-475
-1,621
-24,883
Purchases of investments
-450,934
-441,670
-238,060
-152,031
-108,968
Sales/maturities of investments
392,900
330,700
237,500
36,225
349,193
Net cash used for investing activities
-58,019
-110,970
-1,035
-117,427
215,342
Cash flows from financing activities
Debt repayment
-11,613
-11,613
-5,806
0
0
Common stock issued
-
201,323
119,946
0
117,110
Net cash used provided by (used for) financing activities
190,135
190,154
117,090
3,329
312,540
Net change in cash
-26,379
-79,864
-71,494
-303,153
351,531
Cash at beginning of period
65,242
111,973
183,467
486,620
135,089
Cash at end of period
38,887
32,109
111,973
183,467
486,620
Free cash flow
Operating cash flow
-158,471
-159,158
-187,032
-188,890
-176,360
Capital expenditure
-
-
-475
-1,621
-24,883
Free cash flow
-158,456
-159,158
-187,507
-190,511
-201,243